Biotech, Pharmaceutical & Medical Equipment Auctions & Asset Sales

Ongoing modernization within biotech, pharmaceutical, and medical operations results in surplus laboratory, production, and facility assets as research priorities shift, products reach end of life, and manufacturing footprints evolve. Heritage Global Partners has a long track record supporting asset dispositions within this sector for research laboratories, clinical operations, and regulated manufacturing facilities, including surplus laboratory equipment sales and complete facility liquidations, frequently spanning multiple operational sites.

Heritage Global Partners maintains exclusive master service agreements with Pfizer and Amgen for the disposition of surplus biotech and pharmaceutical assets. Sales in this category originate from research and development transitions, facility consolidations, and corporate restructuring, supporting buyers active in regulated scientific and healthcare environments.

Typical Assets Sold

Current Auctions

Past Auctions

Allied Health Solutions
Online Auction Featuring Pharmaceutical Processing Equipment Formerly of Viatris’ Morgantown Plant, Now Owned By WVU Medicine! Morgantown, WV.

Starting: Feb 21st, 2023 7:00am EDT

Ending: Feb 22nd, 2023 12:00pm EDT

Immediately Accepting Bids
Akorn Pharmaceuticals
Global Online Auction Featuring Pharmaceutical Lab & Process Equipment Formerly of Akorn Pharmaceuticals. Somerset, NJ.

Starting: Feb 13th, 2023 7:00am EDT

Ending: Feb 14th, 2023 10:00am EDT

Immediately Accepting Bids
Activx
Online Auction Featuring Quality Lab Equipment No Longer Required By Activx! San Diego, CA.

Starting: Feb 9th, 2023 7:00am PDT

Ending: Feb 10th, 2023 10:00am PDT

Immediately Accepting Bids
PSS (Pre 2023)
Global Online Auction Featuring Quality Biotech and Pharmaceutical Lab Equipment From Multiple Global Sellers! Multiple Locations, US.

Starting: Feb 6th, 2023 7:00am PDT

Ending: Feb 7th, 2023 7:00am PDT

Immediately Accepting Bids
Catalent (Former Assets)
Global Online Auction Featuring Confectionery & Facility Support Assets Formerly of 2 Catalent Facilities! Roselle, NJ.

Starting: Feb 7th, 2023 7:00am EDT

Ending: Feb 8th, 2023 10:00am EDT

Immediately Accepting Bids
Tanabe
Global Online Auction Featuring Quality Lab Equipment From A Clinical Stage Pharmaceutical Company! San Diego, CA.

Starting: Jan 31st, 2023 7:00am PDT

Ending: Feb 1st, 2023 9:00am PDT

Immediately Accepting Bids
Sesen Bio
Global Online Auction Featuring R&D and Production Equipment Formerly of Sesen Bio! Winnipeg, MB, CAN.

Starting: Jan 11th, 2023 7:00am EDT

Ending: Jan 12th, 2023 10:00am EDT

Immediately Accepting Bids
Rubius
SPECTACULAR OFFERING! Global Online Auction Featuring State of the Art Lab Equipment From Rubius’ Cambridge, MA Lab!

Starting: Jan 9th, 2023 7:00am EDT

Ending: Jan 11th, 2023 10:00am EDT

Immediately Accepting Bids
PSS (Pre 2023)
Global Online Auction Featuring Quality Biotech and Pharmaceutical Lab Equipment From Multiple Global Sellers! Multiple Locations, US.

Starting: Dec 21st, 2022 7:00am EDT

Ending: Dec 22nd, 2022 10:00am EDT

Immediately Accepting Bids
Invitae
Global Online Auction Featuring State of the Art BioPharma Lab Equipment From Invitae’s Irvine Site! Irvine, CA.

Starting: Dec 12th, 2022 7:00am PDT

Ending: Dec 13th, 2022 10:00am PDT

Immediately Accepting Bids

Managing surplus lab or regulated manufacturing assets?

Buyer FAQs

Many cleanroom components, HVAC systems, and lab assets can be reused in non-GMP or pilot-scale applications with modification.
Buyers should evaluate service history, manufacturer support status, software compatibility, and calibration requirements.
Validation documentation may be available when provided by the seller and is disclosed within the listing of assets for sale.

Seller FAQs

Sales are often structured to align with internal QA, EHS, and compliance teams prior to equipment release.
Yes. Asset-only dispositions can be structured without referencing product names or research outcomes.

Sales are often driven by pipeline changes, site consolidations, regulatory strategy shifts, or the retirement of specific research or production programs.